INMB
INmune Bio·NASDAQ
--
--(--)
--
--(--)
INMB Filings
Filing Date
Form Description
Form Type
2026-02-27
Form 8-K - Current report
Key Events
2026-02-27 · Key Events
Form 8-K - Current report
2026-02-23
Form 8-K - Current report
Key Events
2026-02-23 · Key Events
Form 8-K - Current report
2026-02-19
Form 8-K - Current report
Key Events
2026-02-19 · Key Events
Form 8-K - Current report
2026-02-13
Form 8-K - Current report
Key Events
2026-02-13 · Key Events
Form 8-K - Current report
2026-01-27
Form 8-K - Current report
Key Events
2026-01-27 · Key Events
Form 8-K - Current report
2025-12-23
Form 8-K - Current report
Key Events
2025-12-23 · Key Events
Form 8-K - Current report
2025-12-19
Form 8-K - Current report
Key Events
2025-12-19 · Key Events
Form 8-K - Current report
2025-12-19
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-19 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-10
Form 8-K - Current report
Key Events
2025-12-10 · Key Events
Form 8-K - Current report
2025-12-08
Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
2025-12-08 ·
Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
